MYELOMA MINUTE | Up To The Minute News | 5.26.2022 |
|
|
 |
Bispecific Antibodies: The Next Wave of Immunotherapy in Myeloma is Coming! |
In the Spring 2022 Edition of Myeloma Today, IMF Chief Medical Officer Dr. Joseph Mikhael writes about bispecific antibodies — a unique combination of two strategies: a monoclonal antibody that targets myeloma cells and induces the immune system to destroy it; and a monoclonal antibody that engages a local immune cell to directly kill the myeloma cell. He also speaks about its many advantages as compared to other humoral and cellular approaches, such as dual treatment, “off the shelf,” different targets, and broader use. To learn more about bispecific antibodies, read the full publication of the 2022 Spring Edition of Myeloma Today. |
|
 |
Now Accepting Applications: The 2023 Brian D. Novis Research Grants |
The Brian D. Novis Research Grant was established in 1995 to honor IMF co-founder Brian D. Novis, who succumbed to multiple myeloma in July 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2023 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. Deadline for submission of applications is on September 1, 2022. |
|
 |
Watch the Replay: IMF Patient & Family Webinar — New Frontiers in Myeloma Care |
The IMF Patient and Family Webinar on “New Frontiers in Myeloma Care” was held on Saturday, May 14. IMF Chairman Dr. Brian G.M. Durie moderated presentations with the following myeloma experts: Yi Lin, MD, PhD (Mayo Clinic—Rochester, MN), IMF Nurse Leadership Board Member Ann McNeill RN, MSN, APN (John Theurer Cancer Center, Hackensack University Medical Center—Hackensack, NJ), and Nikhil Munshi, MD (Dana-Farber Cancer Institute—Boston, MA). The webinar concluded with a summary panel discussion, a webinar survey, and closing remarks. In case you missed it, you can still watch the replay on the IMF website. |
|
 |
Watch the Replay: IMF Virtual Regional Community Workshop — Midwest |
The IMF Regional Community Workshop — Midwest was held on Saturday, May 21. IMF Senior Director of Regional Community Workshops Kelly Cox kicked off the workshop. Guest speakers included Morie Gertz, MD (Mayo Clinic—Rochester, MN), Al-Ola Abdallah, MD (University of Kansas Medical Center—Kansas City, KS), and IMF Nurse Leadership Board (NLB) Member Teresa Miceli, RN, BSN, OCN (Mayo Clinic—Rochester, MN). In case you missed it, you can still watch the replay on the IMF website. |
|
 |
This Week: Rhode Island Multiple Myeloma Support Group’s Comedy Fundraiser |
The Rhode Island Multiple Myeloma Support Group will be holding a Comedy Fundraiser to benefit the IMF, featuring top local comedians on Friday, May 27 at the Knights of Columbus Hall in Warwick, RI. Doors open at 6:00 p.m., the show starts at 7:00 p.m. Tickets are $20 each. For tickets, donations, or sponsorships, please visit www.funny4funds.com/events. Donations are also currently being accepted through the IMF website. |
|
 |
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series |
Should myeloma patients switch to the generic forms of medications? |
|
|
|
|
We Thank Our Sponsors:
|
Bristol Myers Squibb, GSK, Janssen Oncology, and Karyopharm Therapeutics |
We also thank individuals like you for your continued support! |
|
Join the conversation at The International Myeloma Foundation |
Facebook: /Myeloma | Twitter @IMFMyeloma | Instagram @IMFmyeloma
www.myeloma.org |
This email was sent by: The International Myeloma Foundation 4400 Coldwater Canyon Ave., Suite 300 Studio City, CA 91604 Connect with the IMF InfoLine 1-800-452-2873 |
We respect your privacy and your preferences for communications of this nature. Home • Unsubscribe • Privacy Policy |
View as web page |